AzTrials
AzTrials

Post Traumatic Stress DisorderPrEVENTNCT05874362

People Bereaved by Violent Death : Negative Event Biases and Temporal Perception

A study testing Diagnosis of depressive episode or post traumatic stress disorder and No diagnosis of depressive episode or post traumatic stress disorder in people with Post Traumatic Stress Disorder, run by Hôpital le Vinatier at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

A violent death is defined by its brutality, unexpectedness and is secondary to an external cause (suicide, homicide, accident). Bereavement following a violent death constitutes a particular clinical situation, at risk of complications. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Post Traumatic Stress Disorder
What is being tested?
Diagnosis of depressive episode or post traumatic stress disorder and No diagnosis of depressive episode or post traumatic stress disorder
Could I receive a placebo?
No, everyone receives an active treatment
How many people
61 participants
Where
1 siteFrance
Study dates
19 Sep 2023to 19 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • An age between 18 and 65 years old
  • Recent bereavement by violent death of a relative in first and second degree

Who cannot join

  • Protected adults
  • Lack of mastering French language
  • History of neurodegenerative disorder
  • History of psychiatric disorder treated pharmacologically with modification of the basic treatment in the month preceding the death
  • The take of an benzodiazepine treatment in the 24th hours before the first visit (T0)

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site, 1 recruiting
  • Hopital Vinatier

    Bron, 69678

    LEAUNE EDOUARD, Dr, +33437915120, edouard.leaune@ch-le-vinatier.fr

    Recruiting

Other trials in France

About this study

Official title: People Bereaved by Violent Death : a Negative Event Biases and Temporal Perception Study

A violent death is defined by its brutality, unexpectedness and is secondary to an external cause (suicide, homicide, accident). Bereavement following a violent death constitutes a particular clinical situation, at risk of complications. Research on bereavement after a violent death shows higher risks of psychiatric and somatic complications than in bereavement by non-violent death. These complications, sometimes comorbid, take the form of depressive episodes, post-traumatic stress disorders, suicidal behavior and prolonged grief disorders after 12 months, precociously mediated by ruminations.

Processes responsible for this increased risk of complications are poorly documented. Current literature relates mainly to socio-demographic and epidemiological factors which, alone, do not explain this difference in risks. Further research is needed exploring other kinds of data and processes. To our knowledge, there is no description of early neurocognitive functioning in people bereaved after violent death. This study aims at exploring early neurocognitive processes which can lead to complications in people bereaved by violent death.

Read the detailed description

This work is based on cognitive models of post-traumatic stress disorder involving cognitive biases as factors of development and maintenance of symptomatology. Indeed, in people exposed to a potentially traumatic event, it has been found that an early deterioration in cognitive functioning is a risk factor for developing post-traumatic stress disorders . Among these cognitive alterations, attentional biases toward threat are the most explored and research shows both facilitated engagement and difficulties in disengagement in front of threatening stimuli. In addition, while expecting for a negative event, there is changes in the perception of time . These processes can be explored on a behavioral level and in electroencephalography , in particular through the evoked related potentials following a stimulus. Among these evoked related potentials , the Late Positive Potential component reflects the attentional process, while the Contingent Negative Variation component and the α and β power reflects temporal perception.

As exposure to violent death can have a traumatic impact, our hypothesis is that people bereaved by violent death could present attentional biases, and that these biases would be prodromal of the onset of a psychiatric disorder (Post-traumatic stress disorders , depression afterwards). The objective of this study is to describe the presence of these biases through electrophysiological and behavioral measures in a sample of subjects bereaved by violent death.

Being tested
Diagnosis of depressive episode or post traumatic stress disorder, No diagnosis of depressive episode or post traumatic stress disorder
Medical subject headings
Stress Disorders, Post-Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Diagnosis of depressive episode or post traumatic stress disorderOther

    Clinical diagnosis of depressive episode or post traumatic stress disorder, confirmed

  • No diagnosis of depressive episode or post traumatic stress disorderOther

    No elements in clinical assessment for the diagnosis of a depressive episode or post traumatic stress disorder

Study groups in NCT05874362
Study groupRoleWhat they receive
Group with complications at 3 monthOtherGroup composed with participants who develop a psychiatric complication (depressive episode or post traumatic stress disorder) 3 month after the death of their loved one.
Receives: Other: Diagnosis of depressive episode or post traumatic stress disorder
Group without complication at 3 monthOtherGroup composed with participants who do not develop a psychiatric complication (depressive episode or post traumatic stress disorder) 3 month after the death of their loved one.
Receives: Other: No diagnosis of depressive episode or post traumatic stress disorder

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Amplitude of the Late Positive Potential (LPP) component in unpredictable event condition

    Measure in Electroencephalography (EEG) of the Late Positive Potential (LPP), an Event Related Potential (ERP) relating to attention biases

    Measured: Between Day15 and Day30 after the death of one's loved one

Secondary outcomes (3)
  1. Amplitude of the Contingent Negative Variation (CNV ) component in unpredictable event condition

    Measure in Electroencephalography (EEG) of the Contingent Negative Variation (CNV), EEG measures relating to temporal perception

    Measured: Between Day15 and Day30 after the death of one's loved one

  2. Amplitude of the alpha and beta power in unpredictable event condition

    Measure in Electroencephalography (EEG) of the alpha and beta power, EEG measures relating to temporal perception

    Measured: Between Day15 and Day30 after the death of one's loved one

  3. Comparison of Constant Errors (CE) relative to time estimates in the unpredictability condition (D15-J30) in people developing a psychiatric complication at 3 months and in people not developing these complications.

    Proportion of overestimation of the duration preceding an unpredictable event, and calculation of the point of subjective equality, for measurements of constant errors (CEs) corresponding to the difference between the effective time and the point of subjective equality for each subject

    Measured: Between Day15 and Day30 after the death of one's loved one

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 May 2023
  2. Study start19 Sep 2023
  3. Primary completion19 Sep 2026 (estimated)
  4. Study completion19 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Screening
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
Subjects will be separated into two groups at the end of the study to conduct analyses, depending on the development of a psychiatric complication or not.
Masking
None (open label)
Enrolment
61 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05874362
Sponsor's protocol ID
2023-A00304-41
Acronym
PrEVENT
Status last verified
Jun 2026
First submitted
12 May 2023
Last updated
12 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Diagnosis of depressive episode or post traumatic stress disorder and No diagnosis of depressive episode or post traumatic stress disorder in people with Post Traumatic Stress Disorder, run by Hôpital le Vinatier at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 12 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Laurene LESTIENNE (0033437915120, laurene.lestienne@ch-le-vinatier.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Amplitude of the Late Positive Potential (LPP) component in unpredictable event condition (time frame: Between Day15 and Day30 after the death of one's loved one). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in